These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6392488)

  • 21. High dose melphalan and non-cryopreserved autologous bone marrow treatment of malignant melanoma and neuroblastoma.
    McElwain TJ; Hedley DW; Gordon MY; Jarman M; Millar JL; Pritchard J
    Exp Hematol; 1979; 7 Suppl 5():360-71. PubMed ID: 400698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of megatherapy with autologous bone marrow rescue in solid tumours of childhood.
    Ladenstein R; Hartmann O; Pinkerton CR
    Ann Oncol; 1993; 4 Suppl 1():45-58. PubMed ID: 8338795
    [No Abstract]   [Full Text] [Related]  

  • 23. Fludarabine, cytarabine, granulocyte colony-stimulating factor and melphalan (FALG with L-PAM) as a reduced toxicity conditioning regimen in children with acute leukemia.
    Kato K; Yoshida N; Matsumoto K; Matsuyama T
    Pediatr Blood Cancer; 2014 Apr; 61(4):712-6. PubMed ID: 24376191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-dose melphalan and cyclophosphamide with autologous bone marrow rescue for recurrent/progressive malignant brain tumors in children: a pilot pediatric oncology group study.
    Mahoney DH; Strother D; Camitta B; Bowen T; Ghim T; Pick T; Wall D; Yu L; Shuster JJ; Friedman H
    J Clin Oncol; 1996 Feb; 14(2):382-8. PubMed ID: 8636747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Busulfan, cyclophosphamide and melphalan as conditioning regimen for bone marrow transplantation in children with myelodysplastic syndromes.
    Locatelli F; Pession A; Bonetti F; Maserati E; Prete L; Pedrazzoli P; Zecca M; Prete A; Paolucci P; Cazzola M
    Leukemia; 1994 May; 8(5):844-9. PubMed ID: 8182940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancer.
    Lazarus HM; Herzig RH; Graham-Pole J; Wolff SN; Phillips GL; Strandjord S; Hurd D; Forman W; Gordon EM; Coccia P
    J Clin Oncol; 1983 Jun; 1(6):359-67. PubMed ID: 6366139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allogeneic bone marrow transplantation for plasma cell leukemia following melphalan, cyclophosphamide and total body irradiation.
    De Bock R; Nobels F; Schoemaker I; Van der Planken M; Peetermans M
    Bone Marrow Transplant; 1989 May; 4(3):331. PubMed ID: 2659119
    [No Abstract]   [Full Text] [Related]  

  • 28. High-dose melphalan with autologous hematopoietic stem cell transplantation for acute myeloid leukemia: results of a retrospective analysis of the Italian Pediatric Group for Bone Marrow Transplantation.
    Cesaro S; Meloni G; Messina C; Pillon M; Proglia A; Lanino E; Caniggia M; Bagnulo S; Pession A; Locatelli F;
    Bone Marrow Transplant; 2001 Jul; 28(2):131-6. PubMed ID: 11509930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is treatment intensification by adding etoposide and carboplatin to fractionated total body irradiation and melphalan acceptable in children with solid tumors with respect to toxicity?
    Emminger W; Emminger-Schmidmeier W; Peters C; Hawliczek R; Höcker P; Gadner H
    Bone Marrow Transplant; 1991 Aug; 8(2):119-23. PubMed ID: 1933052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High dose melphalan with autologous marrow rescue in cancer treatment.
    Dewar JM; Forgeson GV; Dady PJ
    N Z Med J; 1984 Nov; 97(768):816-8. PubMed ID: 6390271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. VAMP followed by high dose melphalan and autologous bone marrow transplantation for multiple myeloma.
    McElwain TJ; Gore ME; Meldrum M; Viner C; Judson IR; Malpas JS
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():109-12. PubMed ID: 2697419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Busulphan and melphalan prior to autologous transplantation for myeloid malignancies.
    Cony-Makhoul P; Marit G; Boiron JM; Puntous M; Reiffers J
    Bone Marrow Transplant; 1995 Jul; 16(1):69-70. PubMed ID: 7581131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies.
    Demirer T; Ilhan O; Mandel NM; Arat M; Günel N; Celebi H; Ustün C; Akan H; Demirer S; Aydintuğ S; Uysal A; Koç H
    Bone Marrow Transplant; 2000 Apr; 25(7):697-703. PubMed ID: 10745253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-alkylator non-total-body irradiation regimen with autologous hematopoietic stem-cell transplantation in pediatric solid tumors.
    Ozkaynak MF; Matthay K; Cairo M; Harris RE; Feig S; Reynolds CP; Buckley J; Villablanca JG; Seeger RC
    J Clin Oncol; 1998 Mar; 16(3):937-44. PubMed ID: 9508176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-dose melphalan followed by a second bone marrow transplantation in early relapse of acute myeloid leukemia after bone marrow transplantation in children.
    Tempescul A; Ianotto JC; Eveillard JR; Guillerm G; Berthou C; Marion V; De Braekeleer M
    Ann Hematol; 2008 Jun; 87(6):503-4. PubMed ID: 18172644
    [No Abstract]   [Full Text] [Related]  

  • 36. Teniposide, doxorubicin, melphalan, cisplatin, and total body irradiation with autologous bone marrow transplantation for advanced neuroblastoma.
    Lam-Po-Tang PR; McCowage GB; Vowels MR
    Transplant Proc; 1993 Oct; 25(5):2881-2. PubMed ID: 8212272
    [No Abstract]   [Full Text] [Related]  

  • 37. Phase I study of high-dose continuous intravenous infusion of VP-16 in combination with high-dose melphalan followed by autologous bone marrow transplantation in children with stage IV neuroblastoma.
    Valteau-Couanet D; Vassal G; Pondarré C; Bonnay M; Benhamou E; Couanet D; Plantaz D; Hartmann O
    Bone Marrow Transplant; 1996 Apr; 17(4):485-9. PubMed ID: 8722343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autologous bone marrow transplantation in a child with acute promyelocytic leukemia in second remission.
    Quah TC; Yeoh AE; Sun L
    Singapore Med J; 1997 Aug; 38(8):344-6. PubMed ID: 9364889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The TAM regimen prior to allogeneic and autologous bone marrow transplantation for high-risk acute lymphoblastic leukemias: a cooperative study of 62 patients.
    Cahn JY; Bordigoni P; Souillet G; Pico JL; Plouvier E; Reiffers J; Benz-Lemoine E; Bergerat JP; Lutz P; Colombat P
    Bone Marrow Transplant; 1991 Jan; 7(1):1-4. PubMed ID: 2043871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of Ewing's sarcoma with high-dose melphalan and autologous bone marrow transplantation.
    Cornbleet MA; Corringham RE; Prentice HG; Boesen EM; McElwain TJ
    Cancer Treat Rep; 1981; 65(3-4):241-4. PubMed ID: 7016319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.